Published in
Wiley, Diabetes, Obesity and Metabolism, 4(22), p. 549-556, 2019
DOI: 10.1111/dom.13923
Links
Tools
The effects of dapagliflozin on cardio‐renal risk factors in patients with type 2 diabetes with or without renin‐angiotensin system inhibitor treatment: a post hoc analysis
Journal article published in 2019 by
Rosalie A. Scholtes 
,
Daniël H. van Raalte ,
Daniël H. Raalte,
Ricardo Correa‐Rotter,
Robert D. Toto,
Hiddo J. L. Heerspink ,
Valerie Cain,
C. David Sjöström,
Peter Sartipy,
Bergur V. Stefánsson
,
Daniël H. van Raalte ,
Daniël H. Raalte,
Ricardo Correa‐Rotter,
Robert D. Toto,
Hiddo J. L. Heerspink ,
Valerie Cain,
C. David Sjöström,
Peter Sartipy,
Bergur V. Stefánsson
This paper is made freely available by the publisher.
Full text: Download
Published version:
archiving forbidden
Data provided by 